Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 4891 AL 4905

Biomarker modeling of Alzheimer's disease

Jack CR Jr, Holtzman DM.

Neuron. 2013 Dec 18;80(6):1347-58. doi: 10.1016/j.neuron.2013.12.003.

A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative

Braskie MN, Thompson PM.

Biol Psychiatry. 2014 Apr 1;75(7):527-33. doi: 10.1016/j.biopsych.2013.11.020. Epub 2013 Nov 28.

Immunological aspects and anti-amyloid strategy for Alzheimer's dementia

Liščić RM.

Arh Hig Rada Toksikol. 2013 Dec;64(4):603-8. doi: 10.2478/10004-1254-64-2013-2414.

Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study

Ellis KA, Rainey-Smith SR, Rembach A, Macaulay SL, Villemagne VL; AIBL Research Group.

Int Rev Psychiatry. 2013 Dec;25(6):699-710. doi: 10.3109/09540261.2013.870136.

Preventing cognitive decline in preclinical Alzheimer's disease

Riedel WJ.

Curr Opin Pharmacol. 2014 Feb;14:18-22. doi: 10.1016/j.coph.2013.10.002. Epub 2013 Nov 13.

Adult polyglucosan body disease masquerading as "ALS with dementia of the Alzheimer type": an exceptional phenotype in a rare pathology

Segers K, Kadhim H, Colson C, Duttmann R, Glibert G.

Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):96-9. doi: 10.1097/WAD.0b013e31821cc65d.

Greater responsiveness to donepezil in Alzheimer patients with higher levels of acetylcholinesterase based on attention task scores and a donepezil PET study

Kasuya M, Meguro K, Okamura N, Funaki Y, Ishikawa H, Tanaka N, Iwata R, Yanai K.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):113-8. doi: 10.1097/WAD.0b013e3182222bc0.

Anomalous PiB enhancement in the superior sagittal and transverse venous sinuses

Raymond SB, Cohen AD, Becker C, Price J, Klunk WE.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):186-90. doi: 10.1097/WAD.0b013e31822de18c.

Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial

Saxton J, Hofbauer RK, Woodward M, Gilchrist NL, Potocnik F, Hsu HA, Miller ML, Pejović V, Graham SM, Perhach JL.

J Alzheimers Dis. 2012;28(1):109-18. doi: 10.3233/JAD-2011-110947.

Improvement of the detection of neurodegenerative Alzheimer's disease through a specific surface chemistry applied onto the inner surface of the titration well

Mille C, Debarnot D, Zorzi W, El Moualij B, Coudreuse A, Legeay G, Quadrio I, Perret-Liaudet A, Poncin-Epaillard F.

J Biomater Sci Polym Ed. 2012;23(15):1951-61. doi: 10.1163/092050611X600712. Epub 2012 May 8.

CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial

Kurz A, Thöne-Otto A, Cramer B, Egert S, Frölich L, Gertz HJ, Kehl V, Wagenpfeil S, Werheid K.

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):246-53. doi: 10.1097/WAD.0b013e318231e46e.

The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis

Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M.

J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217.

Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?

Moghbel MC, Saboury B, Basu S, Metzler SD, Torigian DA, Långström B, Alavi A.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):202-8. doi: 10.1007/s00259-011-1960-4.

Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease

Ricci S, Fuso A, Ippoliti F, Businaro R.

J Alzheimers Dis. 2012;28(1):11-24. doi: 10.3233/JAD-2011-110821.

Could cholinesterase inhibitors be harmful over the long term?

Schneider LS.

Int Psychogeriatr. 2012 Feb;24(2):171-4. doi: 10.1017/S1041610211002389.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias